000 | 01974 a2200541 4500 | ||
---|---|---|---|
005 | 20250515085043.0 | ||
264 | 0 | _c20071226 | |
008 | 200712s 0 0 eng d | ||
022 | _a1022-6877 | ||
024 | 7 |
_a10.1159/000104884 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKrook, Aud L | |
245 | 0 | 0 |
_aHepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study. _h[electronic resource] |
260 |
_bEuropean addiction research _c2007 |
||
300 |
_a216-21 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatitis C, Chronic _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethadone _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNarcotics _xadministration & dosage |
650 | 0 | 4 | _aNorway |
650 | 0 | 4 |
_aOpioid-Related Disorders _xepidemiology |
650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 | _aSocial Support |
650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xepidemiology |
700 | 1 | _aStokka, Dorthe | |
700 | 1 | _aHeger, Bernt | |
700 | 1 | _aNygaard, Egil | |
773 | 0 |
_tEuropean addiction research _gvol. 13 _gno. 4 _gp. 216-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000104884 _zAvailable from publisher's website |
999 |
_c17378854 _d17378854 |